ArticleCancer discovery2015
HER2 activating mutations are targets for colorectal cancer treatment.
Shyam M Kavuri et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
189 papers cite itlatest 60 shown
this paperpooled ittrialcites it